Charles Schwab’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-136,167
| Closed | -$630K | – | 3307 |
|
2019
Q1 | $630K | Sell |
136,167
-9,160
| -6% | -$42.4K | ﹤0.01% | 2678 |
|
2018
Q4 | $509K | Sell |
145,327
-6,429
| -4% | -$22.5K | ﹤0.01% | 2765 |
|
2018
Q3 | $1.53M | Buy |
151,756
+25,421
| +20% | +$256K | ﹤0.01% | 2506 |
|
2018
Q2 | $915K | Buy |
126,335
+31,840
| +34% | +$231K | ﹤0.01% | 2606 |
|
2018
Q1 | $571K | Buy |
94,495
+2,925
| +3% | +$17.7K | ﹤0.01% | 2694 |
|
2017
Q4 | $881K | Sell |
91,570
-13,242
| -13% | -$127K | ﹤0.01% | 2546 |
|
2017
Q3 | $931K | Buy |
104,812
+24,869
| +31% | +$221K | ﹤0.01% | 2525 |
|
2017
Q2 | $1.01M | Buy |
79,943
+475
| +0.6% | +$6.01K | ﹤0.01% | 2452 |
|
2017
Q1 | $836K | Buy |
79,468
+4,275
| +6% | +$45K | ﹤0.01% | 2478 |
|
2016
Q4 | $692K | Buy |
75,193
+3,850
| +5% | +$35.4K | ﹤0.01% | 2548 |
|
2016
Q3 | $842K | Sell |
71,343
-4,776
| -6% | -$56.4K | ﹤0.01% | 2448 |
|
2016
Q2 | $985K | Sell |
76,119
-98,129
| -56% | -$1.27M | ﹤0.01% | 2351 |
|
2016
Q1 | $2.79M | Buy |
174,248
+1,578
| +0.9% | +$25.2K | ﹤0.01% | 1878 |
|
2015
Q4 | $4.94M | Buy |
172,670
+96,900
| +128% | +$2.77M | 0.01% | 1525 |
|
2015
Q3 | $2.16M | Buy |
75,770
+15,381
| +25% | +$438K | ﹤0.01% | 2025 |
|
2015
Q2 | $2.17M | Buy |
60,389
+6,011
| +11% | +$216K | ﹤0.01% | 2036 |
|
2015
Q1 | $1.58M | Buy |
54,378
+7,614
| +16% | +$221K | ﹤0.01% | 2178 |
|
2014
Q4 | $986K | Buy |
46,764
+1,220
| +3% | +$25.7K | ﹤0.01% | 2354 |
|
2014
Q3 | $884K | Buy |
45,544
+16,144
| +55% | +$313K | ﹤0.01% | 2359 |
|
2014
Q2 | $460K | Sell |
29,400
-34,830
| -54% | -$545K | ﹤0.01% | 2660 |
|
2014
Q1 | $1.33M | Buy |
64,230
+42,630
| +197% | +$883K | ﹤0.01% | 2147 |
|
2013
Q4 | $279K | Hold |
21,600
| – | – | ﹤0.01% | 2837 |
|
2013
Q3 | $263K | Buy |
+21,600
| New | +$263K | ﹤0.01% | 2811 |
|